John M Karon
Overview
Explore the profile of John M Karon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karon J, Wiegand R, van de Wijgert J, Kilmarx P
J Biopharm Stat
. 2014 Jun;
25(4):812-29.
PMID: 24906060
Laboratory data with a lower quantification limit (censored data) are sometimes analyzed by replacing non-quantifiable values with a single value equal to or less than the quantification limit, yielding possibly...
2.
Wiegand R, Rose C, Karon J
Stat Methods Med Res
. 2014 May;
25(6):2733-2749.
PMID: 24803511
A potential difficulty in the analysis of biomarker data occurs when data are subject to a detection limit. This detection limit is often defined as the point at which the...
3.
Karon J, Wejnert C
J Urban Health
. 2012 Mar;
89(3):565-86.
PMID: 22421885
Time-location sampling (TLS) is useful for collecting information on a hard-to-reach population (such as men who have sex with men [MSM]) by sampling locations where persons of interest can be...
4.
Theiler R, Farr S, Karon J, Paramsothy P, Viscidi R, Duerr A, et al.
Obstet Gynecol
. 2010 May;
115(6):1150-1158.
PMID: 20502284
Objective: To evaluate the presence of and estimate risk factors for reactivation of latent high-risk human papillomavirus (HPV) cervical infection in human immunodeficiency virus (HIV)-infected and HIV-uninfected women. Methods: Data...
5.
McLean C, van de Wijgert J, Jones H, Karon J, McNicoll J, Whitehead S, et al.
AIDS
. 2010 Jan;
24(5):717-22.
PMID: 20098295
Objective: To evaluate the safety, including impact on genital HIV RNA shedding, of Carraguard vaginal gel in HIV-infected women. Design: This is a randomized, controlled, crossover study of Carraguard in...
6.
Karon J, Song R, Brookmeyer R, Kaplan E, Hall H
Stat Med
. 2008 Oct;
27(23):4617-33.
PMID: 18833636
The development of an human immunodeficiency virus (HIV) test that detects recent infection has enabled the U.S. Centers for Disease Control and Prevention (CDC) to estimate annual HIV incidence (number...
7.
van de Wijgert J, Kilmarx P, Jones H, Karon J, Chaikummao S
Contraception
. 2008 Jan;
77(2):122-9.
PMID: 18226677
Background: Candidate vaginal microbicides could cause genital irritation, which in turn could facilitate HIV transmission instead of preventing it. While genital epithelial findings are documented in a standardized manner in...
8.
Song R, Karon J, White E, Goldbaum G
Biometrics
. 2006 Sep;
62(3):838-46.
PMID: 16984327
The analysis of length-biased data has been mostly limited to the interarrival interval of a renewal process covering a specific time point. Motivated by a surveillance problem, we consider a...
9.
Kilmarx P, van de Wijgert J, Chaikummao S, Jones H, Limpakarnjanarat K, Friedland B, et al.
J Acquir Immune Defic Syndr
. 2006 Sep;
43(3):327-34.
PMID: 16980907
Objective: To determine the safety and acceptability of vaginal application of Carraguard, a carrageenan-derived candidate microbicide gel. Design: A randomized, placebo-controlled, triple-blinded clinical trial was conducted in Chiang Rai, northern...
10.
Sullivan P, Karon J, Malitz F, Broyles S, Mokotoff E, Buskin S, et al.
Public Health Rep
. 2005 Sep;
120(3):230-9.
PMID: 16134562
Objectives: The goals of this study were two-fold: (1) to describe methods for drawing a population-based sample of individuals in care for HIV infection and (2) to compare data from...